Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW1229U91, on the consumption of highly palatable energy-rich diet

被引:27
作者
Widdowson, PS [1 ]
Henderson, L
Pickavance, L
Buckingham, R
Tadayyon, M
Arch, JRS
Williams, G
机构
[1] Univ Liverpool, Dept Med, Diabet & Endocrinol Res Unit, Liverpool L69 3GA, Merseyside, England
[2] SmithKline Beecham Pharmaceut, Dept Vasc Biol, Harlow CM19 5AD, Essex, England
关键词
neuropeptide Y; obesity; BW1229U91; hypothalamus; energy balance;
D O I
10.1016/S0196-9781(99)00044-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have studied the hypothalamic activity of the neuropeptide Y (NPY) system in dietary-induced obese male Wistar rats and examined whether the NPY antagonist, BW1229U91, can inhibit the hyperphagia during positive energy balance associated with feeding rats an energy-rich, highly palatable diet. Rats given a highly palatable, high-fat diet became obese after 8 weeks and exhibited hyperinsulinemia and hyperleptinemia, as compared to lean rats fed on standard pellet laboratory diet. Hypothalamic NPY mRNA concentrations were significantly reduced by approximately 70% in dietary-obese rats compared with lean controls, and the former were hypersensitive to intracerebroventricular injections of NPY, possibly as a result of NPY receptor up-regulation. Intracerebroventricular injections of BW1229U91, that inhibits food intake in starved rats, did not alter food intake in either control or obese rats fed either standard pellet diet or the highly palatable diet, respectively. We conclude that dietary-obese rats have underactive hypothalamic NPYergic neurons compared to lean controls, possibly as a result of increased plasma concentrations of leptin and/or insulin that directly inhibit the NPY neuronal activity. The lack of effect of BW1229U91 on the increased caloric intake of dietary-obese rats suggests that the hyperphagia is not NPY-driven and supports the data indicating reduced synaptic activity of the hypothalamic NPY system. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 32 条
[1]   DIET-INDUCED AND DIABETES-INDUCED CHANGES OF OB GENE-EXPRESSION IN RAT ADIPOSE-TISSUE [J].
BECKER, DJ ;
ONGEMBA, LN ;
BRICHARD, V ;
HENQUIN, JC ;
BRICHARD, SM .
FEBS LETTERS, 1995, 371 (03) :324-328
[2]   EFFECTS OF INTRACEREBROVENTRICULAR INJECTION OF NEUROPEPTIDE-Y ON ENERGY-METABOLISM [J].
BILLINGTON, CJ ;
BRIGGS, JE ;
GRACE, M ;
LEVINE, AS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :R321-R327
[3]   DISSOCIATED FEEDING AND HYPOTHERMIC EFFECTS OF NEUROPEPTIDE-Y IN THE PARAVENTRICULAR AND PERIFORNICAL HYPOTHALAMUS [J].
CURRIE, PJ ;
COSCINA, DV .
PEPTIDES, 1995, 16 (04) :599-604
[4]   NEUROPEPTIDE-Y AND ENERGY-BALANCE - ONE-WAY AHEAD FOR THE TREATMENT OF OBESITY [J].
DRYDEN, S ;
FRANKISH, H ;
WANG, Q ;
WILLIAMS, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (05) :293-308
[5]   INCREASED NEUROPEPTIDE-Y SECRETION IN THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS OF OBESE (FA/FA) ZUCKER RATS [J].
DRYDEN, S ;
PICKAVANCE, L ;
FRANKISH, HM ;
WILLIAMS, G .
BRAIN RESEARCH, 1995, 690 (02) :185-188
[6]   NEUROPEPTIDE-Y SUPPRESSES SYMPATHETIC ACTIVITY TO INTERSCAPULAR BROWN ADIPOSE-TISSUE IN RATS [J].
EGAWA, M ;
YOSHIMATSU, H ;
BRAY, GA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :R328-R334
[7]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[8]   NEUROPEPTIDE-Y EFFECTOR SYSTEMS - PERSPECTIVES FOR DRUG DEVELOPMENT [J].
GRUNDEMAR, L ;
HAKANSON, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (05) :153-159
[9]   Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus - Relationship with NPY neurones [J].
Hakansson, ML ;
Hulting, AL ;
Meister, B .
NEUROREPORT, 1996, 7 (18) :3087-3092
[10]  
HEDGE SS, 1995, J PHARMACOL EXP THER, V275, P1261